# FDA Inspection 817417 - Dallas IVF - February 07, 2013

Source: https://www.globalkeysolutions.net/records/fda_inspections/dallas-ivf/fb8a8cd7-5c67-4c62-b492-e35e911f29db/
Source feed: FDA_Inspections

> FDA Inspection 817417 for Dallas IVF on February 07, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 817417
- Company Name: Dallas IVF
- Inspection Date: 2013-02-07
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1234907 - 2024-03-28](https://www.globalkeysolutions.net/api/records/fda_inspections/dallas-ivf/78545a43-2699-4137-9417-f4ac1d0a67ed/)
- [FDA Inspection 1234907 - 2024-03-28](https://www.globalkeysolutions.net/api/records/fda_inspections/dallas-ivf/6ccb41e6-89c3-41ae-ad35-dc3f3b071e8f/)
- [FDA Inspection 1112244 - 2019-12-09](https://www.globalkeysolutions.net/api/records/fda_inspections/dallas-ivf/eeb2b06c-8461-463b-989b-0940d7e41c27/)
- [FDA Inspection 1020991 - 2017-07-11](https://www.globalkeysolutions.net/api/records/fda_inspections/dallas-ivf/76e81478-5ddc-4114-9bc0-ab6553a07232/)
- [FDA Inspection 667829 - 2010-06-17](https://www.globalkeysolutions.net/api/records/fda_inspections/dallas-ivf/e11f4a2e-0d81-4d24-b67c-1dea7e8cd417/)

Company: https://www.globalkeysolutions.net/companies/dallas-ivf/636e12c2-9a7b-4073-ad78-59b91ace0017

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d